Refine
Has Fulltext
- yes (13)
Is part of the Bibliography
- yes (13)
Document Type
- Journal article (13)
Language
- English (13)
Keywords
- multiple myeloma (5)
- CXCR4 (4)
- PET (3)
- medicine (3)
- molecular imaging (3)
- positron emission tomography (3)
- theranostics (3)
- FDG (2)
- PRRT (2)
- bone disease (2)
- 177Lu (1)
- 18FDG-PET/CT (1)
- Antibodies (1)
- Arginine (1)
- CXCR4/SDF-1 (1)
- FDG PET/CT (1)
- FDG-PET/CT (1)
- Hyperkalaemia (1)
- Lysine (1)
- MAG3 (1)
- Multiple myeloma (1)
- Myeloma cells (1)
- Myelomas (1)
- NET (1)
- PET/CT (1)
- Positron emission tomography (1)
- [\(^{68}\)Ga] pentixafor (1)
- \(^{11}\)C-Methionine-PET (1)
- \(^{11}\)C-methionine (1)
- \(^{18}\)F-FDG PET/CT (1)
- \(^{68}\)Ga-Pentixafor (1)
- adenocarcinoma of the lung (1)
- autologous transplantation (1)
- biosynthesis (1)
- bone marrow cells (1)
- cancer (1)
- cancer treatment (1)
- cell staining (1)
- cells (1)
- chemokine receptor (1)
- chemokine receptor-4 (1)
- collagens (1)
- esophagogastric junction (1)
- experience (1)
- extracellular matrix (1)
- glioblastoma (1)
- glioblastoma multiforme (1)
- glioma (1)
- imaging (1)
- imaging techniques (1)
- immunostaining (1)
- in vivo imaging (1)
- involvement (1)
- lesions (1)
- lung and intrathoracic tumors (1)
- macrophages (1)
- magnetic resonance imaging (1)
- malignancies (1)
- management (1)
- microenvironment (1)
- microglial cells (1)
- neuroendocrine tumor (1)
- pleural mesothelioma (1)
- positron emission tomography/computed tomography (1)
- pulmonary imaging (1)
- radionuclide therapy (1)
- renal scintigraphy (1)
- secondary lung tumors (1)
- somatostatin (1)
- stem-cell transplantation (1)
- survival (1)
- trachea (1)
- treatment response (1)
Institute
- Klinik und Poliklinik für Nuklearmedizin (12)
- Medizinische Klinik und Poliklinik II (6)
- Pathologisches Institut (4)
- Abteilung für Molekulare Innere Medizin (in der Medizinischen Klinik und Poliklinik II) (2)
- Institut für Klinische Biochemie und Pathobiochemie (1)
- Institut für Klinische Epidemiologie und Biometrie (1)
- Institut für Medizinische Strahlenkunde und Zellforschung (1)
- Klinik und Poliklinik für Thorax-, Herz- u. Thorakale Gefäßchirurgie (1)
- Lehrstuhl für Tissue Engineering und Regenerative Medizin (1)
- Medizinische Klinik und Poliklinik I (1)
Sonstige beteiligte Institutionen
The aim of this study was to investigate the prognostic value of 18F-fluoro-deoxyglucose positron emission tomography–computed tomography (18F-FDG-PET/CT) in 37 patients with a history of multiple myeloma (MM) and suspected or confirmed recurrence after stem cell transplantation (SCT). All patients had been heavily pre-treated. Time to progression (TTP) and overall survival (OS) were correlated to a number of different PET-derived as well as clinical parameters. Impact on patient management was assessed.
Absence of FDG-avid MM foci was a positive prognostic factor for both TTP and OS (p<0.01). Presence of >10 focal lesions correlated with both TTP (p<0.01) and OS (p<0.05). Interestingly, presence of >10 lesions in the appendicular skeleton proved to have the strongest association with disease progression. Intensity of glucose uptake and presence of extramedullary disease were associated with shorter TTP (p=0.037 and p=0.049, respectively). Manifestations in soft tissue structures turned out to be a strong negative predictor for both, TTP and OS (p<0.01, respectively). PET resulted in a change of management in 30% of patients.
Our data underline the prognostic value of 18F-FDG-PET/CT in MM patients also in the setting of post-SCT relapse. PET/CT has a significant impact on patient management.